“We are very pleased by the overwhelmingly favorable surgeon feedback on the versatility and stable fixation characteristics of Re+Line,” said Rod K. Mayer, president and CEO of the company, in a press release. “This is important to us given the multiple techniques utilized by forefoot surgeons in bunion correction surgery today. Consequently, we anticipate that Re+Line’s unique, low-profile, tension-band plate design will to continue to expand in its applications as we gain more market experience.”
Nextremity Solutions is a privately held medical device company focusing on solutions and approaches for the correction of forefoot pathologies.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
